rs148801784
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 6P and 1B. PM2PP3_StrongBS1_Supporting
The NM_005076.5(CNTN2):c.1695G>A(p.Val565=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,613,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005076.5 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNTN2 | NM_005076.5 | c.1695G>A | p.Val565= | splice_region_variant, synonymous_variant | 13/23 | ENST00000331830.7 | NP_005067.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNTN2 | ENST00000331830.7 | c.1695G>A | p.Val565= | splice_region_variant, synonymous_variant | 13/23 | 1 | NM_005076.5 | ENSP00000330633 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000579 AC: 88AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000680 AC: 171AN: 251288Hom.: 0 AF XY: 0.000641 AC XY: 87AN XY: 135806
GnomAD4 exome AF: 0.00124 AC: 1806AN: 1461844Hom.: 0 Cov.: 32 AF XY: 0.00119 AC XY: 865AN XY: 727226
GnomAD4 genome AF: 0.000579 AC: 88AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.000592 AC XY: 44AN XY: 74306
ClinVar
Submissions by phenotype
Epilepsy, familial adult myoclonic, 5 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change affects codon 565 of the CNTN2 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the CNTN2 protein. This variant also falls at the last nucleotide of exon 13, which is part of the consensus splice site for this exon. This variant is present in population databases (rs148801784, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with CNTN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 474466). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 23, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at